Pamela Morris to Drug Costs
This is a "connection" page, showing publications Pamela Morris has written about Drug Costs.
Connection Strength
0.154
-
Applicability and Cost Implications for Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors Based on the ODYSSEY Outcomes Trial. Circulation. 2019 01 15; 139(3):410-412.
Score: 0.154